Progression in and survival of patients with locally advanced prostate cancer (T3) treated with radical prostatectomy as monotherapy

Journal of Urology

Volumn 160, Issue 4, 1998, Pages 1392-1397

  Van Den Ouden, Dies ^a   Hop, Wim C J ^a   Schröder, Fritz H ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Prostate; Prostatectomy; Survival

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY;

EID: 0032322589     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62546-1     Document Type: Article

References (24)

1. Visser, O. and Horeblas, S.: Incidentie en behandeling van prostaatcarcinoom in de regio van het Integraal Kankercentrum Amsterdam, 1989-1994. Ned. Tijdschr. Geneeskd., 140: 2627, 1996.
2. Goluboff, E. T. and Benson, M. C.: External beam radiation therapy does not offer long-term control of prostate cancer. Urol. Clin. N. Amer., 23: 617, 1996.
3. van den Ouden, D., Bentvelsen, F. M., Boevé, E. R. and Schröder, F. H.: Positive margins after radical prostatectomy: correlation with local recurrence and distant progression. Brit. J. Urol., 72: 489, 1993.
4. Abbas, F. and Scardino, P. T.: Why neoadjuvant androgen deprivation prior to radical prostatectomy is unnecessary. Urol. Clin. N. Amer., 23: 587, 1996.
5. Gomella, L. G., Liberman, S. N., Mulholland, S. G., Petersen, R. O., Hyslop, T. and Corn, B. W.: Induction androgen deprivation plus prostatectomy for stage T3 disease: failure to achieve prostate-specific antigen-based freedom from disease status in a phase II trial. Urology, 47: 870, 1996.
6. Lee, F., Siders, D. B., McHug, T. A., Solomon, M. H. and Klamerus, M. L.: Long-term follow-up of stages T2-T3 prostate cancer pretreated with androgen ablation therapy prior to radical prostatectomy. Anticancer Res., 17: 1507, 1997.
7. Fair W. R., Cookson, M. S., Stroumbakis, N., Cohen, D., Aprikian, A. G., Wang, Y., Russo, P., Soloway, M. S., Sogani, P., Sheinfeld, J., Herr, M., Dalgabni, G., Begg, C. B., Heston, W. D. and Reuter, V. E.: The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostate cancer: Memorial Sloan-Kettering Cancer Center results. Urology, suppl., 49: 46, 1997.
8. Witjes, W. P., Schulman, C. C. and Debruyne, F. M.: Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic carcinoma. Urology, suppl., 49: 65, 1997.
9. Scott, W. W. and Boyd, H. L.: Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience. J. Urol., 101: 86, 1969.
10. Flocks, R. H.: The treatment of stage C prostatic cancer with special reference to combined surgical and radiation therapy. J. Urol., 109: 461, 1973.
11. Schröder, F. H. and Belt, E.: Carcinoma of the prostate: a study of 213 patients with stage C tumors treated by total perineal prostatectomy. J. Urol., 114: 257, 1975.
12. Tomlinson, R. L., Currie, D. P. and Boyce, W. H.: Radical prostatectomy: palliation for stage C carcinoma of the prostate. J. Urol., 117: 85, 1977.
13. Boxer, R. J., Kaufman, J. J. and Goodwin, W. E.: Radical prostatectomy for carcinoma of the prostate: 1951-1976. A review of 329 patients. J. Urol., 117: 208, 1977.
14. Olsson, C. A., Babayan, R. and White, R. D.: Surgical management of stage B or C prostatic carcinoma: radical surgery vs radiotherapy. Urology, suppl., 25: 30, 1985.
15. Morgan, W. R., Bergstralh, E. J. and Zincke, H.: Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. Urology, 41: 113, 1993.
16. Yamada, A. H., Lieskovsky, G., Petrovich, Z., Chen, S. C., Groshen, S. and Skinner, D. G.: Results of radical prostatectomy and adjuvant therapy in the management of locally advanced, clinical stage TC, prostate cancer. Amer. J. Clin. Oncol., 17: 277, 1994.
17. Lerner, S. E., Blute, M. L. and Zincke, H.: Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity. J. Urol., 154: 1447, 1995.
18. van den Ouden, D., Davidson, P. J. T., Hop, W. and Schröder, F. H.: Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. J. Urol., 151: 646, 1994.
19. International Union Against Cancer (UICC): TNM Classification of Malignant Tumors. 4th ed. Edited by P. Hermanek and L. H. Sobin. New York: Springer-Verlag, 1992.
20. Schröder, F. H.: Radical retropubic prostatectomy. In: Genito-Urinary Surgery, 5th ed. Edited by H. N. Whitfield. Oxford: Butterworth-Heinemann, vol. III, p. 419, 1993.
21. van den Ouden, D., Hop, W. C. J., Kranse, R. and Schröder, F. H.: Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostate. Brit. J. Urol., 79: 203, 1997.
22. Schmid, H. P., Mihatsch, M. J., Hering, F. and Rutishauser, G.: Impact of minimal lymph node metastasis on long-term prognosis after radical prostatectomy. Eur. Urol., 31: 11, 1997.
23. Aprikian, A. G., Fair, W. R., Reuter, V. E., Sogani, P., Herr, H., Russo, P. and Sheinfeld, J.: Experience with neoadjuvant diethylstilbestrol and radical prostatectomy in patients with locally advanced prostate cancer. Brit. J. Urol., 74: 630, 1994.
24. Cher, M. L., Shinohara, K., Breslin, S., Vapnek, J. and Carroll, P. R.: High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer. Brit. J. Urol., 75: 771, 1995.